Minneapolis Portfolio Management Group Has Boosted Teva Pharmaceuticals Inds LTD (TEVA) Stake By $2.98 Million, Sio Capital Management Raised Natus Medical (BABY) Holding By $1.19 Million

June 19, 2017 - By Clifton Ray

Sio Capital Management Llc increased Natus Medical Inc (BABY) stake by 62.26% reported in 2016Q4 SEC filing. Sio Capital Management Llc acquired 34,865 shares as Natus Medical Inc (BABY)’s stock declined 11.93%. The Sio Capital Management Llc holds 90,865 shares with $3.16M value, up from 56,000 last quarter. Natus Medical Inc now has $1.18B valuation. The stock rose 0.29% or $0.1 reaching $35.1 per share. About shares traded. Natus Medical Inc (NASDAQ:BABY) has risen 4.38% since June 19, 2016 and is uptrending. It has underperformed by 12.32% the S&P500.

Minneapolis Portfolio Management Group Llc increased Teva Pharmaceuticals Inds Ltd (TEVA) stake by 16.11% reported in 2016Q4 SEC filing. Minneapolis Portfolio Management Group Llc acquired 82,765 shares as Teva Pharmaceuticals Inds Ltd (TEVA)’s stock declined 15.11%. The Minneapolis Portfolio Management Group Llc holds 596,624 shares with $21.63 million value, up from 513,859 last quarter. Teva Pharmaceuticals Inds Ltd now has $32.83B valuation. The stock rose 0.45% or $0.14 reaching $31.06 per share. About 22,074 shares traded. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has declined 41.70% since June 19, 2016 and is downtrending. It has underperformed by 58.40% the S&P500.

Among 25 analysts covering Teva Pharma (NYSE:TEVA), 13 have Buy rating, 0 Sell and 12 Hold. Therefore 52% are positive. Teva Pharma had 60 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was initiated by Credit Suisse with “Neutral” on Wednesday, May 4. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has “Outperform” rating given on Wednesday, July 29 by RBC Capital Markets. The firm has “Buy” rating given on Monday, July 18 by HSBC. The firm has “Hold” rating by Jefferies given on Wednesday, November 16. OTR Global initiated the stock with “Positive” rating in Thursday, September 29 report. The firm earned “Hold” rating on Friday, January 6 by Maxim Group. The firm has “Outperform” rating given on Wednesday, December 7 by Oppenheimer. Wells Fargo initiated the stock with “Outperform” rating in Friday, February 19 report. The company was downgraded on Friday, July 15 by Goldman Sachs. Mizuho downgraded the shares of TEVA in report on Monday, October 24 to “Neutral” rating.

Minneapolis Portfolio Management Group Llc decreased Xylem Inc (NYSE:XYL) stake by 23,826 shares to 377,119 valued at $18.68M in 2016Q4. It also reduced Fedex Corp (NYSE:FDX) stake by 14,428 shares and now owns 185,804 shares. Las Vegas Sands Corp (NYSE:LVS) was reduced too.

Investors sentiment increased to 1.93 in Q4 2016. Its up 0.82, from 1.11 in 2016Q3. It increased, as 11 investors sold BABY shares while 56 reduced holdings. 51 funds opened positions while 78 raised stakes. 29.10 million shares or 6.34% more from 27.36 million shares in 2016Q3 were reported. Gotham Asset Management Limited Liability Company invested 0.07% of its portfolio in Natus Medical Inc (NASDAQ:BABY). Pacad Investment Limited owns 27,823 shares or 0.12% of their US portfolio. First Manhattan has invested 0% in Natus Medical Inc (NASDAQ:BABY). Metropolitan Life Ins Company New York accumulated 23,737 shares or 0.01% of the stock. Rhumbline Advisers reported 48,317 shares. Jpmorgan Chase & holds 215,133 shares or 0% of its portfolio. 7,005 are owned by Fin Advisers Limited Liability Company. Employees Retirement Association Of Colorado invested in 0% or 8,401 shares. Financial Bank Of New York Mellon Corporation accumulated 908,587 shares. Ls Ltd Liability Company, Michigan-based fund reported 1,447 shares. The California-based Los Angeles Capital & Equity Rech has invested 0.01% in Natus Medical Inc (NASDAQ:BABY). Blackrock Fund Advisors reported 0.02% stake. Hutchin Hill Cap Ltd Partnership invested 0.06% in Natus Medical Inc (NASDAQ:BABY). Lpl Finance Llc holds 6,272 shares. Assetmark reported 0% stake.

Among 4 analysts covering Natus Medical (NASDAQ:BABY), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Natus Medical had 7 analyst reports since July 23, 2015 according to SRatingsIntel. The rating was maintained by TH Capital with “Buy” on Thursday, July 23. The firm has “Buy” rating by TH Capital given on Tuesday, January 12. The firm has “Buy” rating given on Thursday, October 22 by TH Capital. Raymond James downgraded the stock to “Mkt Perform” rating in Thursday, February 2 report. As per Tuesday, April 5, the company rating was maintained by Roth Capital. Benchmark initiated it with “Buy” rating and $55 target in Tuesday, October 4 report. The firm has “Outperform” rating by Raymond James given on Tuesday, September 13.

Since February 9, 2017, it had 2 buys, and 3 selling transactions for $190,940 activity. HAWKINS JAMES B bought $135,900 worth of stock. 5,000 shares valued at $163,400 were sold by Engibous Doris on Thursday, May 25. GUNST ROBERT A sold $180,000 worth of stock or 5,000 shares. $186,300 worth of Natus Medical Inc (NASDAQ:BABY) shares were sold by MOORE WILLIAM M.

Sio Capital Management Llc decreased Koninklijke Philips Nv (Call) (NYSE:PHG) stake by 362,662 shares to 100,000 valued at $3.06M in 2016Q4. It also reduced Sarepta Therapeutics Inc (Put) (NASDAQ:SRPT) stake by 51,500 shares and now owns 35,000 shares. Sanofi Sa (Put) (NYSE:SNY) was reduced too.